Dow Up 0.75% Nasdaq Up 1.23%

Geron Corporation (GERN)

-NasdaqGS
2.27 Up 0.06(2.71%) 9:48AM EDT - Nasdaq Real Time Price
Prev Close:2.21
Open:2.26
Bid:2.25 x 600
Ask:2.27 x 2200
1y Target Est:4.13
Beta:2.3
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.24 - 2.30
52wk Range:1.31 - 7.36
Volume:206,630
Avg Vol (3m):1,991,220
Market Cap:356.12M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 2.71%356.12M
BMYDown 0.73%97.12B
GSKUp 0.21%108.74B
NVSUp 0.65%224.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):283.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback